Frede Donskov

Researcher Next ID · RN-006778

Researcher · Medicine

Aarhus, Denmark

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Renal cell carcinoma treatment

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

Renal and related cancers

Bladder and Urothelial Cancer Treatments

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30723-8
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1712126
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510016
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(12)70559-4

No projects listed.